Department of Clinical Neuroscience
At the Department of Clinical Neuroscience (CNS), we conduct research and teaching regarding the function of the brain - from a molecular level to the effect on society.
Individuals with high ADHD-traits are more vulnerable to insomnia
Individuals with high ADHD-traits are more vulnerable to insomnia
Individuals with high ADHD-traits that do not meet the criteria for a diagnosis are less able to perform tasks involving attentional regulation or emotional control after a sleepless night than individuals with low ADHD-traits, a new study from Karolinska Institutet published in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging reports.
Hopes of new treatment strategies for glaucoma
Hopes of new treatment strategies for glaucoma
In the search for new ways to treat the incurable eye disease glaucoma, researchers at Karolinska Institutet and St. Erik Eye Hospital have discovered more clues as to its pathogenesis. A new study shows how metabolic disturbance of the neurons coincide with raised pressure in the eye. In animal and cell models, rapamycin and pyruvate treatments were shown to have a protective effect. The study is published in the journal PNAS.
Lecture on Climate Change with Alasdair Skelton from the Department Day 2019
Professor Kristina Alexanderson awarded the 2020 Silver Medal
Professor Kristina Alexanderson awarded the 2020 Silver Medal
Kristina Alexanderson, Professor of Social Insurance at the Department of Clinical Neuroscience is awarded the medal for her excellent contribution to the development of social insurance research and competence at KI. She has placed KI firmly on the map as a leading university in the field, nationally as well as internationally.
New clues about the link between stress and depression
New clues about the link between stress and depression
Researchers at the Department of Clinical Neuroscience have identified a protein in the brain that is important both for the function of the mood-regulating substance serotonin and for the release of stress hormones, at least in mice. The findings, which are published in the journal Molecular Psychiatry, may have implications for the development of new drugs for depression and anxiety.
Key gene identified for improving MS treatment
Key gene identified for improving MS treatment
The disease multiple sclerosis (MS) attacks the central nervous system and, with time, can give rise to muscle tremors and loss of balance. Researchers at Karolinska Institutet have now identified a gene, Gsta4, that protects a certain kind of cell in the brain from being destroyed. It is hoped that the results of the study, which is published in Nature Communications, can help to improve the treatment of this serious disease.
Environment and Sustainable Development at CNS
We as part of a University has a central roll in the work to combat climate change, both by contributing through teaching and research, but we also need to contribute by reducing the impact of our own activities. Here you can find tips on what changes you can do in your daily life to reduce your climate footprint.
GDPR at KI
The General Data Protection Regulation (GDPR, or Dataskyddsförordningen) for the processing of personal data is to be applied on May 25 2018 in Sweden. Here you will find information on GDPR and the implementation of the regulation at KI.